204 related articles for article (PubMed ID: 15361791)
1. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects.
Eriksson EE
Curr Opin Lipidol; 2004 Oct; 15(5):553-8. PubMed ID: 15361791
[TBL] [Abstract][Full Text] [Related]
2. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
Huo Y; Schober A; Forlow SB; Smith DF; Hyman MC; Jung S; Littman DR; Weber C; Ley K
Nat Med; 2003 Jan; 9(1):61-7. PubMed ID: 12483207
[TBL] [Abstract][Full Text] [Related]
3. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.
von Hundelshausen P; Weber KS; Huo Y; Proudfoot AE; Nelson PJ; Ley K; Weber C
Circulation; 2001 Apr; 103(13):1772-7. PubMed ID: 11282909
[TBL] [Abstract][Full Text] [Related]
4. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics.
Bursill CA; Channon KM; Greaves DR
Curr Opin Lipidol; 2004 Apr; 15(2):145-9. PubMed ID: 15017357
[TBL] [Abstract][Full Text] [Related]
5. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte recruitment to atherosclerotic lesions.
Cybulsky MI; Won D; Haidari M
Can J Cardiol; 2004 Aug; 20 Suppl B():24B-28B. PubMed ID: 15309201
[TBL] [Abstract][Full Text] [Related]
7. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury.
Schober A; Manka D; von Hundelshausen P; Huo Y; Hanrath P; Sarembock IJ; Ley K; Weber C
Circulation; 2002 Sep; 106(12):1523-9. PubMed ID: 12234959
[TBL] [Abstract][Full Text] [Related]
8. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.
Combadière C; Potteaux S; Gao JL; Esposito B; Casanova S; Lee EJ; Debré P; Tedgui A; Murphy PM; Mallat Z
Circulation; 2003 Feb; 107(7):1009-16. PubMed ID: 12600915
[TBL] [Abstract][Full Text] [Related]
9. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment.
Heller EA; Liu E; Tager AM; Sinha S; Roberts JD; Koehn SL; Libby P; Aikawa ER; Chen JQ; Huang P; Freeman MW; Moore KJ; Luster AD; Gerszten RE
Circulation; 2005 Jul; 112(4):578-86. PubMed ID: 16043658
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.
Veillard NR; Kwak B; Pelli G; Mulhaupt F; James RW; Proudfoot AE; Mach F
Circ Res; 2004 Feb; 94(2):253-61. PubMed ID: 14656931
[TBL] [Abstract][Full Text] [Related]
12. CXCL4-induced macrophages in human atherosclerosis.
Domschke G; Gleissner CA
Cytokine; 2019 Oct; 122():154141. PubMed ID: 28899579
[TBL] [Abstract][Full Text] [Related]
13. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium.
Mause SF; von Hundelshausen P; Zernecke A; Koenen RR; Weber C
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1512-8. PubMed ID: 15890969
[TBL] [Abstract][Full Text] [Related]
14. Fractalkine--a local inflammatory marker aggravating platelet activation at the vulnerable plaque.
Flierl U; Schäfer A
Thromb Haemost; 2012 Sep; 108(3):457-63. PubMed ID: 22739755
[TBL] [Abstract][Full Text] [Related]
15. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.
Imai T; Hieshima K; Haskell C; Baba M; Nagira M; Nishimura M; Kakizaki M; Takagi S; Nomiyama H; Schall TJ; Yoshie O
Cell; 1997 Nov; 91(4):521-30. PubMed ID: 9390561
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte influx in atherosclerosis.
Galkina E; Ley K
Curr Drug Targets; 2007 Dec; 8(12):1239-48. PubMed ID: 18220701
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived chemokines in atherogenesis: what's new?
Gleissner CA
Curr Vasc Pharmacol; 2012 Sep; 10(5):563-9. PubMed ID: 22338571
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
[TBL] [Abstract][Full Text] [Related]
19. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
[TBL] [Abstract][Full Text] [Related]
20. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice.
Koenen RR; von Hundelshausen P; Nesmelova IV; Zernecke A; Liehn EA; Sarabi A; Kramp BK; Piccinini AM; Paludan SR; Kowalska MA; Kungl AJ; Hackeng TM; Mayo KH; Weber C
Nat Med; 2009 Jan; 15(1):97-103. PubMed ID: 19122657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
